Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial
Keith D. Lindor(Mayo Clinic), Patrick Colin, Kris V. Kowdley(Liver Institute Northwest), Paul Angulo(University of Kentucky), Roberta A. Jorgensen(Mayo Clinic), Edwyn M Harrison(Mayo Clinic in Arizona), Lawrence J. Burgart(Mayo Clinic), Jenny Heathcote(University of Toronto), James Lymp(Mayo Clinic)
Cited by 729
Related Papers
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis
|Journal of Hepatology|1999|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k